Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  CNS and Neurological Disorders - Drug Targets

• Publication date

  2012-02-29

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/187152712800269731PMID 22483283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alterations of Endocannabinoid Signaling, Synaptic Plasticity, Learning, and Memory in Monoacylglycerol Lipase Knock-out Mice

  2011cited by this paper
• Spinal Cord Injuries Induce Changes in CB1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions

  2011cited by this paper
• CB2: a cannabinoid receptor with an identity crisis

  2010cited by this paper
• 1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice.

  2010cited by this paper
• Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice.

  2010cited by this paper
• A CB(2) receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: contributions of spinal and peripheral CB(2) receptors.

  2009cited by this paper
• Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.

  2009cited by this paper
• Periaqueductal gray neurons project to spinally projecting GABAergic neurons in the rostral ventromedial medulla

  2008cited by this paper
• Are opioid-sensitive neurons in the rostral ventromedial medulla inhibitory interneurons?

  2008cited by this paper
• Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats

  2008cited by this paper
• Cannabinoids for the treatment of neuropathic pain: clinical evidence.

  2008cited by this paper
• First in Vivo Evidence for a Functional Interaction between Chemokine and Cannabinoid Systems in the Brain

  2008cited by this paper
• Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid‐1 receptors after peripheral nerve injury in rats

  2007cited by this paper
• Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats.

  2007cited by this paper
• Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.

  2007cited by this paper
• Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double‐blind, placebo‐controlled clinical trial

  2007cited by this paper
• CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a

  2007cited by this paper
• Development and expression of neuropathic pain in CB1 knockout mice.

  2006cited by this paper
• Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors

  2006cited by this paper
• Site‐specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain

  2006cited by this paper
• Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes

  2006cited by this paper
• Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system

  2006cited by this paper
• Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing.

  2006cited by this paper
• Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats

  2005cited by this paper
• Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons.

  2005cited by this paper
• Chemically Distinct Ligands Promote Differential CB1 Cannabinoid Receptor-Gi Protein Interactions

  2005cited by this paper
• Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.

  2005cited by this paper
• Repeated treatment with the synthetic cannabinoid WIN 55,212‐2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain

  2004cited by this paper
• State-dependent opioid control of pain

  2004cited by this paper
• Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain

  2004cited by this paper
• Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET

  2004cited by this paper
• Antihyperalgesic effect of the cannabinoid agonist WIN55,212-2 is mediated through an interaction with spinal metabotropic glutamate-5 receptors in rats.

  2004cited by this paper
• Isoflurane Differentially Modulates Medullary ON and OFF Neurons While Suppressing Hind-limb Motor Withdrawals

  2004cited by this paper
• Discharge of Raphe Magnus on and offCells Is Predictive of the Motor Facilitation Evoked by Repeated Laser Stimulation

  2003cited by this paper
• Upregulation of spinal cannabinoid‐1‐receptors following nerve injury enhances the effects of Win 55,212‐2 on neuropathic pain behaviors in rats

  2003cited by this paper
• Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

  2003cited by this paper
• Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

  2003cited by this paper
• Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity

  2002cited by this paper
• Interaction between vanilloid and glutamate receptors in the central modulation of nociception.

  2002cited by this paper
• Modulation of transmitter release via presynaptic cannabinoid receptors.

  2001cited by this paper
• Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception.

  2001cited by this paper
• The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

  2001cited by this paper
• Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.

  2000cited by this paper
• Pain modulation: expectation, opioid analgesia and virtual pain.

  2000cited by this paper
• Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

  1998cited by this paper
• An analgesia circuit activated by cannabinoids

  1998cited by this paper
• The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain.

  1997cited by this paper
• Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.

  1996cited by this paper
• Functional characteristics of the midbrain periaqueductal gray.

  1995cited by this paper
• Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla.

  1995cited by this paper
• Interference with GABA transmission in the rostral ventromedial medulla: disinhibition of off-cells as a central mechanism in nociceptive modulation.

  1994cited by this paper
• Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: firing of on- and off-cells is related to nociceptive responsiveness.

  1989cited by this paper
• A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

  1988cited by this paper
• Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission.

  1986cited by this paper
• Relative contributions of the nucleus raphe magnus and adjacent medullary reticular formation to the inhibition by stimulation in the periaqueductal gray of a spinal nociceptive reflex in the pentobarbital-anesthetized rat.

  1984cited by this paper
• Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry.

  1984cited by this paper
• The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat

  1983cited by this paper
• Ethical guidelines for investigations of experimental pain in conscious animals.

  1983cited by this paper

• A type-5 metabotropic glutamate receptor-perineuronal net axis shapes the function of cortical GABAergic interneurons in chronic pain

  2025cites this paper
• Metabotropic Glutamate Receptor 5: A Potential Target for Neuropathic Pain Treatment

  2024cites this paper
• The endocannabinoid system in the brain undergoes long-lasting changes following neuropathic pain

  2024influential citation
• Activation of Cannabinoid Receptor 1 in GABAergic Neurons in the Rostral Anterior Insular Cortex Contributes to the Analgesia Following Common Peroneal Nerve Ligation

  2023cites this paper
• Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphine.

  2023cites this paper
• NAPE-PLD regulates specific baseline affective behaviors but is dispensable for inflammatory hyperalgesia

  2023cites this paper
• Role of Cannabinoid Receptors in Crocin-Induced Hypoalgesia in Neuropathic Pain in Rats

  2020cites this paper
• Cannabinoids in the descending pain modulatory circuit: Role in inflammation.

  2020cites this paper
• Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel

  2020cites this paper
• Paracetamol is a centrally acting analgesic using mechanisms located in the periaqueductal grey

  2019cites this paper
• Ultra-micronized palmitoylethanolamide rescues the cognitive decline-associated loss of neural plasticity in the neuropathic mouse entorhinal cortex-dentate gyrus pathway.

  2019cites this paper
• Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain

  2019cites this paper
• Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain

  2019cites this paper
• Metabotropic glutamate receptor subtype 7 in the dorsal striatum oppositely modulates pain in sham and neuropathic rats

  2018cites this paper
• Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization-Induced Suppression of Excitation in the Anterior Cingulate Cortex

  2018cites this paper
• Synthetic peripherally‐restricted cannabinoid suppresses chemotherapy‐induced peripheral neuropathy pain symptoms by CB1 receptor activation

  2018cites this paper
• Novel analgesic effects of melanin-concentrating hormone on persistent neuropathic and inflammatory pain in mice

  2018cites this paper
• Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain

  2017cites this paper
• Nociception modulation by supraspinal group III metabotropic glutamate receptors

  2017cites this paper
• Loss of dopamine D1 receptors and diminished D1/5 receptor-mediated ERK phosphorylation in the periaqueductal gray after spinal cord lesion.

  2017cites this paper
• mGLU Receptors

  2017cites this paper
• Supraspinal Metabotropic Glutamate Receptors: An Endogenous Substrate for Alleviating Chronic Pain and Related Affective Disorders

  2017cites this paper
• Neuroplasticity of Supraspinal Structures Associated with Pathological Pain

  2017cites this paper
• Dissecting the Signaling Pathways Involved in the Crosstalk between Metabotropic Glutamate 5 and Cannabinoid Type 1 Receptors

  2016cites this paper
• Central nucleus of the amygdala in descending control of pain-related behavior

  2015cites this paper
• Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain.

  2015cites this paper
• Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond

  2014cites this paper
• Peripheral gating of pain signals by endogenous analgesic lipids

  2014cites this paper
• Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions.

  2014cites this paper
• Peripheral gating of pain signals by endogenous lipid mediators

  2014cites this paper
• Dynamic changes to the endocannabinoid system in models of chronic pain

  2012cites this paper